Core Scientific, Inc. CORZ
17.34
(0.79)
(4.36%)
as of 25 Sep
- Market cap
- $5.9B
- P/E
- 0.0×
Follow CORZ
Insider Buys
alert about insiders buying in the last 12 month
| Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
2.60 | 2.60 | 2.60 | 2.60 | 7.04 | 14.52 |
P/FCF ratio |
27.16 | 27.16 | 27.16 | 27.16 | 0.00 | 0.00 |
P/Operating CF |
60.21 | 60.21 | 60.21 | 60.21 | 260.37 | 30.26 |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
3.90 | 3.90 | 3.90 | 3.90 | 7.50 | 16.86 |
EV/EBITDA |
18.43 | 18.43 | 18.43 | 18.43 | 0.00 | 0.00 |
EV/Operating CF |
30.05 | 30.05 | 30.05 | 30.05 | 89.32 | 19.34 |
EV/FCF |
40.67 | 40.67 | 40.67 | 40.67 | (73.26) | (11.76) |
Quick Ratio |
— | 0.42 | 0.28 | 0.14 | 6.22 | 0.40 |
Current Ratio |
— | 2.36 | 0.46 | 0.20 | 6.72 | 1.15 |
Net Debt/EBITDA |
0.00 | 3.51 | 0.23 | 6.12 | (13.03) | (4.70) |
Debt/Assets |
0.00% | 29.29% | 0.00% | 101.08% | 72.77% | 45.17% |
Debt/Equity |
0.00 | 0.53 | 0.00 | (1.21) | (1.14) | (1.10) |
Asset Turnover |
0.00 | 0.45 | 0.39 | 0.66 | 0.47 | 0.17 |
Operating CF/Net income |
1.05 | (1.20) | (0.10) | (0.26) | (0.03) | (0.96) |
Capex/Depreciation |
(0.15) | (1.69) | (0.31) | (0.17) | (0.77) | (8.54) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 0.00% | 0.00% | (460.65%) | 48.99% | 186.74% | 30.29% | |
| 0.00% | 3.88% | (132.22%) | (32.44%) | (131.43%) | (15.10%) | |
ROIC |
0.00% | 4.27% | 0.00% | 10.53% | 0.00% | 0.00% |
Return on Tangible Assets |
0.00% | 4.58% | (364.12%) | (127.04%) | (119.54%) | (20.51%) |
Average Days of Receivables |
0.00 | 1.13 | 0.15 | 0.73 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
8.74% | 1.41% | 4.21% | 21.52% | 22.26% | 49.91% |
Selling, General and Administrative Expense of Revenue |
27.06% | 11.85% | 35.30% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.44 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
5.03% | 7.15% | 28.56% | 11.72% | 10.17% | 30.79% |
Graham Net Nets |
(0.93) | (0.93) | (0.93) | (0.93) | (0.42) | (0.52) |
Graham Number |
0.00 | 5.76 | 13.05 | 4.77 | 21.10 | 9.65 |
Earnings Yield |
(18.70%) | (18.70%) | (18.70%) | (18.70%) | (38.22%) | (9.38%) |
Free Cash Flow Yield |
3.68% | 3.68% | 3.68% | 3.68% | (1.45%) | (9.88%) |
Revenue per Share |
0.38 | 2.63 | 1.88 | 1.32 | 2.00 | 1.00 |
Operating CF per Share |
(0.15) | (0.27) | 0.60 | 0.17 | 0.17 | 0.87 |
Capex per Share |
(0.01) | (0.28) | (1.73) | (0.04) | (0.37) | (2.31) |
Free Cash Flow per Share |
(0.16) | (0.56) | (1.13) | 0.13 | (0.20) | (1.44) |
Cash per Share |
0.00 | 0.64 | 0.15 | 0.18 | 3.27 | 0.98 |
Shareholders Equity per Share |
0.00 | 6.47 | (1.20) | (1.57) | (3.69) | (3.03) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 6.47 | (1.20) | (1.57) | (3.69) | (3.03) |
Free Cash Flow |
(25.33) | (115.31) | (385.62) | 48.12 | (52.30) | (457.50) |
Working Capital |
— | 436.27 | (101.69) | (391.41) | 769.40 | 114.14 |
Capital Expenditures |
(1.57) | (58.57) | (590.81) | (16.99) | (95.19) | (735.75) |
Net Current Asset Value |
0.00 | (341.09) | (1,131.93) | (1,212.08) | (1,515.03) | (2,414.85) |
EV/EBIT |
218.37 | 218.37 | 218.37 | 218.37 | 0.00 | 0.00 |
Capex to Sales |
0.03 | 0.11 | 0.92 | 0.03 | 0.19 | 2.31 |
Net Profit Margin |
(37.61%) | 8.69% | (335.20%) | (49.06%) | (281.57%) | (90.47%) |
Price to Operating Income |
145.82 | 145.82 | 145.82 | 145.82 | 0.00 | 0.00 |
| Other line items | ||||||
Depreciation/Fixed assets |
0.00 | 0.06 | 2.72 | 0.17 | 0.29 | 0.07 |
Cash ROIC |
0.00% | (29.90%) | 136.08% | (270.16%) | (40.35%) | (248.20%) |
Accounts Receivable Turnover |
0.00 | 0.00 | 660.46 | 798.73 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 19.37 | 3.64 | 4.48 | 3.87 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 13.87 | 30.98 | 149.06 | 18.05 | 163.73 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | — | 0.97 | 0.63 | — | — |
Average Payables |
— | — | 32.63 | 104.20 | 87.01 | 72.69 |
Average Assets |
— | 1,219.43 | 1,623.28 | 759.92 | 1,094.05 | 1,911.80 |
Average Common Equity |
— | — | 465.93 | (503.14) | (770.00) | (952.89) |
Columns are period end dates